Mengying Ke

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

B4GALT3 as a Key Glycosyltransferase Gene in Multiple Myeloma Progression: Insights From Bioinformatics, Machine Learning, and Experimental Validation.

B4GALT3 as a Key Glycosyltransferase Gene in Multiple Myeloma Progression: Insights From Bioinformatics, Machine Learning, and Experimental Validation.

Journal: Molecular carcinogenesis

Published: February 27, 2025

SAE1 promotes tumor cell malignancy via SUMOylation and liquid-liquid phase separation facilitated nuclear export of p27.

SAE1 promotes tumor cell malignancy via SUMOylation and liquid-liquid phase separation facilitated nuclear export of p27.

Journal: Acta pharmaceutica Sinica. B

Published: August 21, 2024

Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation.

Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation.

Journal: Aging

Published: May 08, 2023

GART Functions as a Novel Methyltransferase in the RUVBL1/β-Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer.

GART Functions as a Novel Methyltransferase in the RUVBL1/β-Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 24, 2023

G6PD promotes cell proliferation and dexamethasone resistance in multiple myeloma via increasing anti-oxidant production and activating Wnt/β-catenin pathway.

G6PD promotes cell proliferation and dexamethasone resistance in multiple myeloma via increasing anti-oxidant production and activating Wnt/β-catenin pathway.

Journal: Experimental hematology & oncology

Published: May 14, 2022

Untargeted serum metabolomics reveals specific metabolite abnormalities in patients with Crohn's disease.

Untargeted serum metabolomics reveals specific metabolite abnormalities in patients with Crohn's disease.

Journal: Frontiers in medicine

Published: November 14, 2021

Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy.

Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy.

Journal: Frontiers in endocrinology

Published: September 22, 2021

Acupuncture Synergized With Bortezomib Improves Survival of Multiple Myeloma Mice via Decreasing Metabolic Ornithine.

Acupuncture Synergized With Bortezomib Improves Survival of Multiple Myeloma Mice via Decreasing Metabolic Ornithine.

Journal: Frontiers in oncology

Published: September 19, 2021

Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients.

Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients.

Journal: Journal of translational medicine

Published: August 15, 2021

CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients.

CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients.

Journal: Journal of hematology & oncology

Published: April 14, 2021

Serum lipidomics reveals distinct metabolic profiles for asymptomatic hyperuricemic and gout patients.

Serum lipidomics reveals distinct metabolic profiles for asymptomatic hyperuricemic and gout patients.

Journal: Rheumatology (Oxford, England)

Published: March 14, 2021

BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability.

BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability.

Journal: Signal transduction and targeted therapy

Published: March 04, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026